These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 33598950)
41. Swab pooling: A new method for large-scale RT-qPCR screening of SARS-CoV-2 avoiding sample dilution. Christoff AP; Cruz GNF; Sereia AFR; Boberg DR; de Bastiani DC; Yamanaka LE; Fongaro G; Stoco PH; Bazzo ML; Grisard EC; Hernandes C; de Oliveira LFV PLoS One; 2021; 16(2):e0246544. PubMed ID: 33539474 [TBL] [Abstract][Full Text] [Related]
42. Assessing the dilution effect of specimen pooling on the sensitivity of SARS-CoV-2 PCR tests. Bateman AC; Mueller S; Guenther K; Shult P J Med Virol; 2021 Mar; 93(3):1568-1572. PubMed ID: 32936471 [TBL] [Abstract][Full Text] [Related]
43. Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease - Florida, 2016. Bingham AM; Cone M; Mock V; Heberlein-Larson L; Stanek D; Blackmore C; Likos A MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):475-8. PubMed ID: 27171533 [TBL] [Abstract][Full Text] [Related]
44. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters. Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640 [TBL] [Abstract][Full Text] [Related]
45. Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens. Wang H; Hogan CA; Miller JA; Sahoo MK; Huang C; Mfuh KO; Sibai M; Zehnder J; Hickey B; Sinnott-Armstrong N; Pinsky BA Emerg Infect Dis; 2021 Jan; 27(1):92-103. PubMed ID: 33183494 [TBL] [Abstract][Full Text] [Related]
46. Residual risk and waste in donated blood with pooled nucleic acid testing. Aprahamian H; Bish DR; Bish EK Stat Med; 2016 Dec; 35(28):5283-5301. PubMed ID: 27488928 [TBL] [Abstract][Full Text] [Related]
47. Group testing regression model estimation when case identification is a goal. Zhang B; Bilder CR; Tebbs JM Biom J; 2013 Mar; 55(2):173-89. PubMed ID: 23401252 [TBL] [Abstract][Full Text] [Related]
48. Regression models for disease prevalence with diagnostic tests on pools of serum samples. Vansteelandt S; Goetghebeur E; Verstraeten T Biometrics; 2000 Dec; 56(4):1126-33. PubMed ID: 11129470 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of sample pooling for screening of SARS CoV-2. Mulu A; Alemayehu DH; Alemu F; Tefera DA; Wolde S; Aseffa G; Seyoum T; Habtamu M; Abdissa A; Bayih AG; Beyene GT PLoS One; 2021; 16(2):e0247767. PubMed ID: 33635923 [TBL] [Abstract][Full Text] [Related]
50. Semiparametric regression models for a right-skewed outcome subject to pooling. Mitchell EM; Lyles RH; Manatunga AK; Schisterman EF Am J Epidemiol; 2015 Apr; 181(7):541-8. PubMed ID: 25737248 [TBL] [Abstract][Full Text] [Related]
51. Household representative sample strategy for COVID-19 large-scale population screening. Takyi-Williams J Med Hypotheses; 2020 Nov; 144():110200. PubMed ID: 33254509 [TBL] [Abstract][Full Text] [Related]
52. Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010. Zhou Z; Mitchell RM; Gutman J; Wiegand RE; Mwandama DA; Mathanga DP; Skarbinski J; Shi YP Malar J; 2014 Dec; 13():509. PubMed ID: 25522751 [TBL] [Abstract][Full Text] [Related]
53. Estimating covariate-adjusted measures of diagnostic accuracy based on pooled biomarker assessments. McMahan CS; McLain AC; Gallagher CM; Schisterman EF Biom J; 2016 Jul; 58(4):944-61. PubMed ID: 26927583 [TBL] [Abstract][Full Text] [Related]
54. Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis. Pareek M; Eborall HC; Wobi F; Ellis KS; Kontopantelis E; Zhang F; Baggaley R; Hollingsworth TD; Baines D; Patel H; Haldar P; Patel M; Stephenson I; Browne I; Gill P; Kapur R; Farooqi A; Abubakar I; Griffiths C BMJ Open; 2019 Mar; 9(3):e029188. PubMed ID: 30850420 [TBL] [Abstract][Full Text] [Related]
55. Pooled Saliva Specimens for SARS-CoV-2 Testing. Barat B; Das S; De Giorgi V; Henderson DK; Kopka S; Lau AF; Miller T; Moriarty T; Palmore TN; Sawney S; Spalding C; Tanjutco P; Wortmann G; Zelazny AM; Frank KM medRxiv; 2020 Oct; ():. PubMed ID: 33052363 [TBL] [Abstract][Full Text] [Related]
56. A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus. Liu P; Shi ZX; Zhang YC; Xu ZC; Shu HS; Zhang XY Transfusion; 1997 Jul; 37(7):732-6. PubMed ID: 9225938 [TBL] [Abstract][Full Text] [Related]
57. The objective function controversy for group testing: Much ado about nothing? Hitt BD; Bilder CR; Tebbs JM; McMahan CS Stat Med; 2019 Oct; 38(24):4912-4923. PubMed ID: 31469188 [TBL] [Abstract][Full Text] [Related]
58. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies. van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834 [TBL] [Abstract][Full Text] [Related]
59. Reduction of the cost of testing for antibody to human immunodeficiency virus, without losing sensitivity, by pooling sera. Babu PG; Saraswathi NK; Vaidyanathan H; John TJ Indian J Med Res; 1993 Jan; 97():1-3. PubMed ID: 8486402 [TBL] [Abstract][Full Text] [Related]